Filing Details
- Accession Number:
- 0001209191-10-004899
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-26 12:00:00
- Reporting Period:
- 2010-01-22
- Filing Date:
- 2010-01-26
- Accepted Time:
- 2010-01-26 18:31:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1339455 | Somaxon Pharmaceuticals Inc. | SOMX | Pharmaceutical Preparations (2834) | 200161599 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1346901 | Jeffrey Raser | Somaxon Pharmaceuticals, Inc. 3830 Valley Centre Drive, Suite 705-461 San Diego CA 92130 | Senior Vp, Sales And Marketing | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-01-22 | 44,674 | $2.60 | 47,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $2.44 to $2.72 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.